KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Return on Capital Employed (2016 - 2025)

Pacific Biosciences Of California has reported Return on Capital Employed over the past 15 years, most recently at 0.77% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.77% for Q4 2025, down 40.0% from a year ago — trailing twelve months through Dec 2025 was 0.77% (down 40.0% YoY), and the annual figure for FY2025 was 0.58%, down 25.0%.
  • Return on Capital Employed for Q4 2025 was 0.77% at Pacific Biosciences Of California, up from 0.89% in the prior quarter.
  • Over the last five years, Return on Capital Employed for PACB hit a ceiling of 0.1% in Q2 2021 and a floor of 0.89% in Q3 2025.
  • Median Return on Capital Employed over the past 5 years was 0.2% (2022), compared with a mean of 0.34%.
  • Biggest five-year swings in Return on Capital Employed: soared 160bps in 2021 and later tumbled -63bps in 2025.
  • Pacific Biosciences Of California's Return on Capital Employed stood at 0.1% in 2021, then plummeted by -102bps to 0.2% in 2022, then grew by 4bps to 0.19% in 2023, then crashed by -90bps to 0.37% in 2024, then plummeted by -109bps to 0.77% in 2025.
  • The last three reported values for Return on Capital Employed were 0.77% (Q4 2025), 0.89% (Q3 2025), and 0.88% (Q2 2025) per Business Quant data.